HomeLIPO • NASDAQ
add
Lipella Pharmaceuticals Inc
Previous close
$2.18
Day range
$2.22 - $2.83
Year range
$1.97 - $12.00
Market cap
11.53M USD
Avg Volume
118.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 129.39K | -11.30% |
Operating expense | 463.74K | -10.98% |
Net income | -1.31M | -9.63% |
Net profit margin | -1.01K | -23.60% |
Earnings per share | — | — |
EBITDA | -1.33M | -9.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.23M | 100.68% |
Total assets | 4.86M | 54.79% |
Total liabilities | 776.85K | 34.90% |
Total equity | 4.08M | — |
Shares outstanding | 4.47M | — |
Price to book | 1.36 | — |
Return on assets | -88.17% | — |
Return on capital | -109.37% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.31M | -9.63% |
Cash from operations | -1.43M | -2.71% |
Cash from investing | — | — |
Cash from financing | 3.47M | 1,633.14% |
Net change in cash | 2.04M | 271.67% |
Free cash flow | -949.06K | 0.99% |
About
Founded
2005
Headquarters
Website
Employees
5
